Antithrombotic Therapy for Atrial Fibrillation

Author:

You John J.,Singer Daniel E.,Howard Patricia A.,Lane Deirdre A.,Eckman Mark H.,Fang Margaret C.,Hylek Elaine M.,Schulman Sam,Go Alan S.,Hughes Michael,Spencer Frederick A.,Manning Warren J.,Halperin Jonathan L.,Lip Gregory Y.H.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference175 articles.

1. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study;Lloyd-Jones;Circulation,2004

2. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence;Miyasaka;Circulation,2006

3. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study;Wolf;Stroke,1991

4. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials [published correction in Arch Intern Med. 1994;154(19):2254];Arch Intern Med,1994

5. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines;Douketis;Chest,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3